SOLIQUA

Google image searchProduct monograph

Active ingredients

insulin glargine, 100 UNIT/ML

lixisenatide, 33 MCG/ML

DIN: 02478293

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 12-SEP-2018

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AE — Insulins and analogues for injection, long-acting (ATC, ATC/DDD)
• A10AE54 — INSULIN GLARGINE AND LIXISENATIDE (ATC/DDD)

Reference brand drug: Soliqua

External Links for Soliqua

Search on Google

• Soliqua side effects
• Soliqua dosage
• insulin glargine side effects
• insulin glargine dosage
• lixisenatide side effects
• lixisenatide dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find soliqua photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.